Three experts say that pulmonary rehabilitation programs don’t necessarily result in improved lung function but are associated with improved physical and other sorts of functioning. Less than 5% of those who might benefit from pulmonary rehabilitation services received them.
Carolyn L. Rochester, M.D., Martijn A. Spruit, PT, Ph.D., and Anne Holland, PT, Ph.D., recently published a concise, 1.5 page review article in about the current status of pulmonary rehabilitation programs for patients with chronic respiratory diseases in JAMA. Here are five takeaways from their article:
Anne Holland
Carolyn Rochester
Martijn Spruit
ATS Guidelines Highlight Benefits of Pulmonary Rehabilitation
February 7th 2025Patients with chronic obstructive pulmonary disease, interstitial lung disease and pulmonary hypertension experience improved quality of life and functional capacity as measured in the 6-minute walk distance test.
Read More
Remote Care Advancement for Heart Failure, COPD and Diabetes Patients
February 24th 2021In this week's episode of Tuning In to the C-Suite podcast, MHE's Briana Contreras spoke with Dr. Rob Kowal, chief medical officer of the Cardiac Rhythm and Heart Failure division at Medtronic. The two discussed how remote monitoring and IoT is changing healthcare and how remote technology is also gaining a wide-spread adoption to monitor patients at home who have chronic conditions like heart failure, chronic obstructive pulmonary disease and diabetes.
Listen
Refoxy Pharmaceuticals Secures $9.7 Million to Explore Innovative Treatment for IPF
January 4th 2025Conventional drug development typically zeroes in on individual proteins or signaling pathways. By focusing on the transcription factor FOXO3, Refoxy hopes to harness a key regulator that impacts numerous biological processes.
Read More
Study Highlights Critical Need For Improved Understanding of Childhood Interstitial Lung Disease
December 10th 2024Diagnostic criteria for pulmonary fibrosis and other fibrotic diseases in children are lacking. That void hampers an understanding of how disease progresses in children and adolescents and what the outcomes are.
Read More